Effects of estradiol on myocardial global performance index in hypertensive postmenopausal women

Gynecological Endocrinology

Volumn 19, Issue 5, 2004, Pages 282-292

  Aldrighi, J M ^a,c   Alecrin, I N ^a   Caldas, M A ^a   Gebara, O C E ^a   Ramires, J A F ^a   Rosano, G M C ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IRCCS San Raffael   (Italy)

^c NONE   (Brazil)

Author keywords

Doppler echocardiography; Myocardial performance index; Postmenopausal

Indexed keywords

ESTRADIOL; PLACEBO;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART PROTECTION; HORMONAL REGULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBSTITUTION THERAPY; VASCULAR RESISTANCE;

ADULT; AGED; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERTENSION; LUTEINIZING HORMONE; MIDDLE AGED; MYOCARDIUM; PLACEBOS; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 12344334566     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400017464     Document Type: Article

References (45)

1. American Heart Association. (2002) Heart and Stroke Statistical Update. Dallas: American Heart Association, 2002:1-38
2. American Heart Association. A Statement for Healthcare professionals from the American Heart Association. Cardiovascular disease in women. Circulation 1996;96:2468-82
3. Eaker E, Chesebro JH, Sacks FM, et al. Cardiovascular disease in women. Circulation 1993;88:1999-2009
4. Capewell S, MacIntyre K, Stewart S. Age, sex and social trends in out-of- hospital cardiac deaths in Scotland 1986-1995: a retrospective cohort study Lancet 2001;358:3-7
5. Sperlman J, Wolff P, Finucane F, et al. Menopause and the epidemiology of cardiovascular disease in women. Prog Clin Biol Res 1989;320:283-90
6. Gaspard UJ, Gottal J-M, den Brule FA. Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 1995;21:171-8
7. Folsom AR, Wu KK, Davis CE, et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205
8. Sullivan JM, Fowlkes LP. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol 1996;8 (Suppl 2):365-403
9. Staessen J, Bulpitt CJ, Fagard R, et al. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427-33
10. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641-6
11. Tremollieres FA, Poulles JM, Cauneille C, et al. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999; 142:415-23
12. Roccella EJ, Bowler AE. Hypertension as a risk factor. Cardiovasc Clin 1990;20:49-63
13. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105:1503-8
14. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normal and dilated cardiomyopathy. J Cardiol 1995;26:357-66
15. Poulsen SH, Jensen SE, Tei C, et al. Value of the Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000;13:723-30
16. Voutilainen S, Kupari M, Hippelainen M, et al. Factors influencing Doppler indexes of left ventricular filling in a healthy person. Am J Cardiol 1991;68:653-9
17. Benjamin EJ, Levy D, Anderson KM, et al. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol 1992;70:508-15
18. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-62
19. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women - for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-13
20. Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002;288:321-33
21. Voutilainen S, Hippelainen M, Hulkko S, et al. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol 1993;71:614-17
22. Fak AS, Erenus M, Tezcan H, et al. Effects of single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction. Fertil Steril 2000;73:66-71
23. Pines A, Fisman EZ, Shemesh J, et al. Menopause-related changes in left ventricular function in heathy women. Cardiology 1992;80:413-16
24. Pines A, Fisman EZ, Averbuch M, et al. The long-term effects of transdermal estradiol on left ventricular function and dimensions. Eur Menopause J 1995;2:22-5
25. Volterrani M, Rosano G, Coats A, et al. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995;99:119-22
26. World Heath Organization. Research on the Menopause in the 1990s. Report of a WHO scientific group. Geneva: WHO, 1996
27. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-46
28. Oh JK, Appleton CP, Hade LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr 1997;10:246-70
29. Sahn DJ, De Maria A, Kisslo J, et al. The committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantization in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58: 1072-83
30. Schiller NB, Shah PM, Crawford M. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67
31. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8
32. Garcia MJ, Thomas J, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-72
33. Pines A, Fisman EZ, Levo Y, et al. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1993;72:240-1
34. Pines A, Pisman FZ, Shapira I, et al. Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension. Am J Cardiol 1996; 78:1385-9
35. Kangro T, Henriksen E, Jonason T, et al. Effects of menopause on left ventricular filling in 50-year-old women. Am J Cardiol 1995;76:1093-6
36. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353:571-80
37. Nishimura RA, Abel MD, Hatle LK, et al. Assessment of diastolic function of the heart: background and current applications of doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc 1989;64:181-204
38. Berkalp B, Cesur V, Corapcioglu D, et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol 1995;52:23-6
39. Morano I, Gagelmann M, Arner A, et al. Myosin isoenzymes of vascular smooth cardiac muscle in the spontaneously hypertensive and normotensive male and female rat: a comparative study. Circ Res 1986; 59:456-62
40. Malhotra A, Buttrick P, Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 1990;259:H866-71
41. Yusuf S, Sleight P, Pogues J. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evalution Study Investigators. N Engl J Med 2000;342:145-53
42. Liebson PR, Grandits G, Primeas R, et al. (1993). Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87:476-86
43. Snabes MC, Payne JP, Kopelen HA, et al. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Obstet Gynecol 1997;89:332-9
44. Fisman EZ, Tenenbaum A, Shapira I, et al. The acute effects of sublingual estradiol on left ventricular diastolic function in normotensive and hypertensive postmenopausal women. Maturitas 1999;33:145-52
45. Spirito P, Maron BJ, Bonow RO. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol 1986;7:518-26